Chapter/Section Purchase

1 Study Coverage
1.1 Candidiasis Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Candidiasis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Doxorubicin
1.2.3 Cisplatin
1.2.4 7Carboplatin
1.2.5 Etoposide
1.2.6 Ifosfamide
1.2.7 Cyclophosphamide
1.2.8 Methotrexate
1.2.9 Vincristine
1.3 Market by Application
1.3.1 Global Candidiasis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Multispecialty Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Candidiasis Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Candidiasis Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Candidiasis Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Candidiasis Therapeutics Sales by Region
2.4.1 Global Candidiasis Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales Candidiasis Therapeutics by Region (2023-2028)
2.5 Global Candidiasis Therapeutics Revenue by Region
2.5.1 Global Candidiasis Therapeutics Revenue by Region (2017-2022)
2.5.2 Global Candidiasis Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Candidiasis Therapeutics Sales by Manufacturers
3.1.1 Global Top Candidiasis Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Candidiasis Therapeutics in 2021
3.2 Global Candidiasis Therapeutics Revenue by Manufacturers
3.2.1 Global Candidiasis Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Candidiasis Therapeutics Revenue in 2021
3.3 Global Candidiasis Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Candidiasis Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Candidiasis Therapeutics Sales by Type
4.1.1 Global Candidiasis Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Candidiasis Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Candidiasis Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Candidiasis Therapeutics Revenue by Type
4.2.1 Global Candidiasis Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Candidiasis Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Candidiasis Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Candidiasis Therapeutics Price by Type
4.3.1 Global Candidiasis Therapeutics Price by Type (2017-2022)
4.3.2 Global Candidiasis Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Candidiasis Therapeutics Sales by Application
5.1.1 Global Candidiasis Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Candidiasis Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Candidiasis Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Candidiasis Therapeutics Revenue by Application
5.2.1 Global Candidiasis Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Candidiasis Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Candidiasis Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Candidiasis Therapeutics Price by Application
5.3.1 Global Candidiasis Therapeutics Price by Application (2017-2022)
5.3.2 Global Candidiasis Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Candidiasis Therapeutics Market Size by Type
6.1.1 North America Candidiasis Therapeutics Sales by Type (2017-2028)
6.1.2 North America Candidiasis Therapeutics Revenue by Type (2017-2028)
6.2 North America Candidiasis Therapeutics Market Size by Application
6.2.1 North America Candidiasis Therapeutics Sales by Application (2017-2028)
6.2.2 North America Candidiasis Therapeutics Revenue by Application (2017-2028)
6.3 North America Candidiasis Therapeutics Market Size by Country
6.3.1 North America Candidiasis Therapeutics Sales by Country (2017-2028)
6.3.2 North America Candidiasis Therapeutics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Candidiasis Therapeutics Market Size by Type
7.1.1 Europe Candidiasis Therapeutics Sales by Type (2017-2028)
7.1.2 Europe Candidiasis Therapeutics Revenue by Type (2017-2028)
7.2 Europe Candidiasis Therapeutics Market Size by Application
7.2.1 Europe Candidiasis Therapeutics Sales by Application (2017-2028)
7.2.2 Europe Candidiasis Therapeutics Revenue by Application (2017-2028)
7.3 Europe Candidiasis Therapeutics Market Size by Country
7.3.1 Europe Candidiasis Therapeutics Sales by Country (2017-2028)
7.3.2 Europe Candidiasis Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Candidiasis Therapeutics Market Size by Type
8.1.1 Asia Pacific Candidiasis Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific Candidiasis Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Candidiasis Therapeutics Market Size by Application
8.2.1 Asia Pacific Candidiasis Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific Candidiasis Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Candidiasis Therapeutics Market Size by Region
8.3.1 Asia Pacific Candidiasis Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific Candidiasis Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Candidiasis Therapeutics Market Size by Type
9.1.1 Latin America Candidiasis Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America Candidiasis Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Candidiasis Therapeutics Market Size by Application
9.2.1 Latin America Candidiasis Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America Candidiasis Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Candidiasis Therapeutics Market Size by Country
9.3.1 Latin America Candidiasis Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America Candidiasis Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Candidiasis Therapeutics Market Size by Type
10.1.1 Middle East and Africa Candidiasis Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Candidiasis Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Candidiasis Therapeutics Market Size by Application
10.2.1 Middle East and Africa Candidiasis Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Candidiasis Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Candidiasis Therapeutics Market Size by Country
10.3.1 Middle East and Africa Candidiasis Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Candidiasis Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis AG Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis AG Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd. Overview
11.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Bayer-Algeta
11.4.1 Bayer-Algeta Corporation Information
11.4.2 Bayer-Algeta Overview
11.4.3 Bayer-Algeta Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bayer-Algeta Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer-Algeta Recent Developments
11.5 Merrion Pharmaceuticals Plc.
11.5.1 Merrion Pharmaceuticals Plc. Corporation Information
11.5.2 Merrion Pharmaceuticals Plc. Overview
11.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merrion Pharmaceuticals Plc. Recent Developments
11.6 Ablynx
11.6.1 Ablynx Corporation Information
11.6.2 Ablynx Overview
11.6.3 Ablynx Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ablynx Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ablynx Recent Developments
11.7 Genta Incorporated
11.7.1 Genta Incorporated Corporation Information
11.7.2 Genta Incorporated Overview
11.7.3 Genta Incorporated Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Genta Incorporated Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Genta Incorporated Recent Developments
11.8 Galapagos NV
11.8.1 Galapagos NV Corporation Information
11.8.2 Galapagos NV Overview
11.8.3 Galapagos NV Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Galapagos NV Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Galapagos NV Recent Developments
11.9 Catena Pharmaceuticals Inc.
11.9.1 Catena Pharmaceuticals Inc. Corporation Information
11.9.2 Catena Pharmaceuticals Inc. Overview
11.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Catena Pharmaceuticals Inc. Recent Developments
11.10 Digna Biotech S.L.
11.10.1 Digna Biotech S.L. Corporation Information
11.10.2 Digna Biotech S.L. Overview
11.10.3 Digna Biotech S.L. Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Digna Biotech S.L. Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Digna Biotech S.L. Recent Developments
11.11 Medivir AB
11.11.1 Medivir AB Corporation Information
11.11.2 Medivir AB Overview
11.11.3 Medivir AB Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Medivir AB Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Medivir AB Recent Developments
11.12 Amura Holdings
11.12.1 Amura Holdings Corporation Information
11.12.2 Amura Holdings Overview
11.12.3 Amura Holdings Candidiasis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Amura Holdings Candidiasis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amura Holdings Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Candidiasis Therapeutics Industry Chain Analysis
12.2 Candidiasis Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Candidiasis Therapeutics Production Mode & Process
12.4 Candidiasis Therapeutics Sales and Marketing
12.4.1 Candidiasis Therapeutics Sales Channels
12.4.2 Candidiasis Therapeutics Distributors
12.5 Candidiasis Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Candidiasis Therapeutics Industry Trends
13.2 Candidiasis Therapeutics Market Drivers
13.3 Candidiasis Therapeutics Market Challenges
13.4 Candidiasis Therapeutics Market Restraints
14 Key Findings in The Global Candidiasis Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer